Welcome
The mathematician of the Complutense University of Madrid, José-Vidal Ruiz Varela, argues that Europe must raise its borrowing limit, leaving its deflationary policy.
SAN FRANCISCO (MarketWatch)
Pfizer Inc. PFE -0.42% said late Monday that an experimental Alzheimer's treatment it's working on with Johnson & Johnson Inc. unit Janssen Pharmaceuticals did not meet clinical endpoints in a late-stage study
In the study, a certain class of patients with mild-to-moderate Alzheimer's disease given an intravenous form of the drug bapineuzumab did not fare any better in cognitive and functional performance compared with those given a placebo, Pfizer said
The Phase III drug study is one of four that Pfizer is partnering on with the J&J unit
The three other studies of the drug will continue as planned, Pfizer said
No hay comentarios:
Publicar un comentario